Colorectal cancer is one of the deadliest forms of cancer in the United States. The risk of developing colorectal cancer is ...

Biodexa Pharmaceuticals PLC Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX) ...

Many people put them off since they’re invasive and expensive, which has led to millions falling behind on their routine ...

Advanced cases may lead to fluid buildup in the abdomen, causing visible swelling. In women, appendix cancer may mimic ...

Compared to stool DNA testing, researchers found that CT colonography is a cost-saving and clinically effective method for ...

Recursion Pharmaceuticals continues to have a pipeline of drugs that might provide further validation for the company's ...

People with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care. Recent ...

In a worrisome health trend, a recent study from Vanderbilt University Medical Center has revealed that appendix cancer cases ...

Appendix cancer cases have quadrupled among millennials, according to a new study. Learn about early symptoms, possible ...

1 Ben Towne Center for Childhood Cancer Research, Seattle Children’s Research Institute, Seattle, WA, United States 2 UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, WA, ...

According to the National Cancer Information Center, the incidence of colorectal cancer in Korea in 2022 is 61.1 per 100,000 ...

Biodexa Pharmaceuticals ( ($BDRX) ) just unveiled an announcement. On June 4, 2025, Biodexa Pharmaceuticals announced the recruitment of the first ...